AR and prostate carcinoma: Rearrangements that alter AR gene structure and splicing patterns have been described in prostate cancer cell lines, and xenografts which suggests the origin of AR-V7 might be derived from intragenic AR gene rearrangements or premature translation termination by aberrant mRNA splicing10–12.